[Alzheimer's disease].
Alzheimer's disease is the most common neurodegenerative disease encountered in patients over 60 years. By its prevalence and the consequent individual and social loss of function Alzheimer's disease is a major public health problem. With the presentation of a clinical story of Alzheimer's disease in an elderly patient, we propose a diagnostic and therapeutic discussion on this clinical problem. We must adjust the treatment for each patient and overall not omit the non pharmacological therapeutic approaches.
Jedidi
H
H
Service de Neurologie, CHU de Liège, Centre de la mémoire, Aspirant FNRS.
Jedidi
Z
Z
Salmon
E
E
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D000975:Antioxidants / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy; D015928:Cognitive Behavioral Therapy; D003937:Diagnosis, Differential; D015259:Dopamine Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015577:Geriatric Assessment; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012307:Risk Factors; D012720:Severity of Illness Index; D012944:Social Support
D000975:Antioxidants; D002800:Cholinesterase Inhibitors; D015259:Dopamine Agents